|
Comorbiditiesb
|
|
Hypertension
|
96 (42.5)
| |
|
DM
|
23 (10.2)
| |
|
Hyperlipidemia
|
25 (11.1)
| |
|
Cardiovascular disease
|
22 (9.7)
| |
|
Nephropathy
|
17 (7.5)
| |
|
Disease duration (year)C
|
5 (2–12)
| |
|
Number of flares/last yearC
|
3 (1.25–12)
| |
|
Stage of goutb
|
|
Asymptomatic (hyperuricemia)
|
8 (3.5)
| |
|
Acute phase
|
128 (56.6)
| |
|
Intercritical phase
|
37 (16.4)
| |
|
Chronic phase
|
53 (23.5)
| |
|
Number of tophib
|
|
No
|
136 (60.2)
| |
|
1
|
37 (16.4)
| |
|
≥ 2
|
53 (23.5)
| |
|
sUA (μmol/L)a
|
468.15 ± 116.59
| |
|
Presence of tender joints, yesb
|
190 (84.1)
| |
|
Presence of swollen joints, yesb
|
162 (71.7)
| |
|
Total pain (VAS)C
|
4.25(0–7.75)
| |
|
Urate lowering therapyb
|
|
Allopurinol
|
16 (7.1)
| |
|
Febuxostat
|
80 (35.4)
| |
|
Any anti-inflammatory drugsb
|
|
Colchicine
|
146 (64.6)
| |
|
NSAID
|
105 (46.5)
| |
|
Corticosteroids
|
71 (31.4)
| |
